EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer

Ankita Shrivastava, Eric Nels Pederson, Trang Uyen Nguyen, Jacky Chuen, Prathibha Mohan, Shivangi Pande, Ana Ruiz Toribio, Nicolas Lecomte, Jerry Melchor, John C McAuliffe, Paul M Grandgenett, Vinagolu K Rajasekhar und 7 weitere

Cell Reports · 2026

DOI: 10.1016/j.celrep.2026.117520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Ankita Shrivastava und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, Stem Cell and Cancer Biology Program, Immunotherapy for Cancer and Inflammatory Disorders, Cancer Dormancy Inst…. Hauptthemen laut MEDLINE: Protein Biosynthesis, RNA, Messenger, Proto-Oncogene Proteins p21(ras), Mutation. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein BiosynthesisRNA, MessengerProto-Oncogene Proteins p21(ras)MutationNeoplasmsHumansTOR Serine-Threonine KinasesCell Line, TumorRibosomesEukaryotic Initiation Factor-4E5' Untranslated RegionsAnimalsSignal TransductionEukaryotic Initiation Factor-4A

Stichwörter der Autor:innen

CP: cancerCP: molecular biologyEEF1AEIF4AKRAS inhibitorsRibosomemRNA translationmTOR signalingmutant KRASoncogenic signalingribosome profilingribosome stalling, pancreatic cancer

Substanzen

RNA, MessengerProto-Oncogene Proteins p21(ras)TOR Serine-Threonine KinasesKRAS protein, humanEukaryotic Initiation Factor-4E5' Untranslated RegionsEukaryotic Initiation Factor-4A

Autor:innen und Institutionen

  • Department of Molecular Pharmacology, Stem Cell and Cancer Biology Program, Immunotherapy for Cancer and Inflammatory Disorders, Cancer Dormancy Institute, Data Science Institute, Albert Einstein College of Medicine, Mo…
  • Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA.
  • David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
  • Department of Surgery and Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA.
  • Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

Förderung

  • NICHD NIH HHS
  • NCI NIH HHS
  • NCATS NIH HHS
  • NIH
  • National Cancer Institute
  • Albert Einstein College of Medicine, Yeshiva University
  • Einstein-Montefiore CFAR
  • Institute for Clinical and Translational Research, University of Wisconsin, Madison

Zitieren

APA

Shrivastava, A., Pederson, E. N., Nguyen, T. U., Chuen, J., Mohan, P., Pande, S., Toribio, A. R., Lecomte, N., Melchor, J., McAuliffe, J. C., Grandgenett, P. M., Rajasekhar, V. K., Nishikawa, K., Knörlein, A., David, Y., Willis, I. M., Iacobuzio-Donahue, C. A., Ouyang, Z., & Singh, K. (2026). Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117520

Vancouver

Shrivastava A, Pederson EN, Nguyen TU, Chuen J, Mohan P, Pande S, et al. Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117520

BibTeX
@article{Shrivastava2026,
  author = {Shrivastava, Ankita and Pederson, Eric Nels and Nguyen, Trang Uyen and Chuen, Jacky and Mohan, Prathibha and Pande, Shivangi and Toribio, Ana Ruiz and Lecomte, Nicolas and Melchor, Jerry and McAuliffe, John C and Grandgenett, Paul M and Rajasekhar, Vinagolu K and Nishikawa, Kaila and Knörlein, Anna and David, Yael and Willis, Ian M and Iacobuzio-Donahue, Christine A and Ouyang, Zhengqing and Singh, Kamini},
  title = {Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer},
  journal = {Cell Reports},
  year = {2026},
  doi = {10.1016/j.celrep.2026.117520}
}
Kostenlos starten →